NY Times

DECEMBER 18, 2020

The Food and Drug Administration authorized a second coronavirus vaccine for emergency use, clearing the way for millions more Americans to be immunized next week.

Vaccines 104

Vaccines Immunity Immunization Nursing Homes 104

European Pharmaceutical Review

AUGUST 2, 2023

A new COVID-19 vaccine has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). Bimervax is now the ninth vaccine to be authorised by the UK’s independent medicines regulator to treat the virus. This is an additional ingredient designed to trigger a stronger immune response.

Vaccines 98

Vaccines Immunity Immunization 98

NY Times

DECEMBER 11, 2020

British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.

Vaccines 145

Vaccines Immunity Immunization 145

European Pharmaceutical Review

JANUARY 26, 2024

A paper, published in Nature Chemical Biology has reported the first ‘free-from ‘tree’ production of a key vaccine ingredient sourced from the soapbark tree. Bioengineering vaccine adjuvants The paper explained: “QS-21 is a potent vaccine adjuvant currently sourced by extraction from the Chilean soapbark tree.

Vaccines 98

Vaccines Compounding Immunity Immunization 98

NY Times

MAY 5, 2021

pharmaceutical industry, came out in favor of waiving intellectual property protections for coronavirus vaccines. The Biden administration, siding with some world leaders over the U.S.

Vaccines 141

Vaccines Immunity Immunization 141

NY Times

JULY 1, 2021

The Pfizer and Moderna vaccines are safe and effective. Full approval from the F.D.A. will help stop the spread of Covid-19.

Vaccines 145

Vaccines Immunity Immunization 145

European Pharmaceutical Review

NOVEMBER 18, 2022

The World Health Organization (WHO)’s Global Vaccine Market Report 2022 , the first report to examine the impact of COVID-19 on the global vaccine market, shows that inequitable distribution is not unique to COVID-19 vaccines, with poorer countries consistently fighting to access vaccines in demand by wealthier countries.

Vaccines 98

Vaccines Immunity Immunization Documentation 98

NY Times

DECEMBER 25, 2020

Until now, reports of severe reactions had been linked to the Pfizer vaccine. The patient, who has a severe shellfish allergy, recovered quickly with treatment.

Vaccines 145

Vaccines Immunization Immunity 145

NY Times

FEBRUARY 8, 2022

A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory.

Vaccines 145

Vaccines Immunity Immunization 145

NY Times

MARCH 23, 2022

The company said the vaccine produced a strong immune response in children younger than 6, but proved only about 40 percent effective in preventing symptomatic Covid-19.

Vaccines 98

Vaccines Immunity Immunization 98

NY Times

AUGUST 20, 2021

Federal regulators are winding down the process of licensing Pfizer’s two-dose coronavirus vaccine, setting up an approval possibly by Monday and possibly kicking off a wave of new mandates.

Vaccines 145

Vaccines Immunity Immunization 145

NY Times

OCTOBER 9, 2021

Some poorer countries are paying more and waiting longer for the company’s vaccine than the wealthy — if they have access at all.

Vaccines 145

Vaccines Immunity Immunization 145

NY Times

AUGUST 3, 2021

The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.

Vaccines 145

Vaccines Hospitals Immunity Immunization 145

pharmaphorum

JULY 21, 2022

GSK’s former head of vaccines R&D – Dr Emmanuel Hanon – is heading up a new biotech called Vicebio that will go up against his former employer with a vaccine against respiratory syncytial virus (RSV) infections. ” The post Ex-GSK vaccine chief to lead new UK biotech Vicebio appeared first on. . ” He said.

Vaccines 105

Vaccines Immunity Immunization 105

NY Times

JANUARY 26, 2021

President Biden said the amount of coronavirus vaccines reaching the states would rise next week and a deal was near to provide enough shots to vaccinate nearly all Americans by the end of summer.

Vaccines 131

Vaccines Immunity Immunization 131

NY Times

OCTOBER 21, 2021

The company said that in a study, boosters cut down the number of breakthrough infections among fully vaccinated people by more than 95 percent.

Vaccines 145

Vaccines Immunity Immunization 145

NY Times

MARCH 4, 2021

Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior.

Vaccines 134

Vaccines Immunity Immunization 134

NY Times

JUNE 11, 2021

The agency has not decided whether to allow a troubled vaccine factory in Baltimore to reopen.

Vaccines 123

Vaccines Immunity Immunization 123

NY Times

FEBRUARY 5, 2021

Covid cases fell dramatically and quickly among people who were vaccinated, Israeli studies found. It’s the strongest evidence yet that a robust vaccination program can tame the pandemic.

Vaccines 108

Vaccines Immunity Immunization 108

NY Times

MAY 28, 2021

The single-dose vaccine becomes the fourth vaccine to be authorized for use in Britain.

Vaccines 97

Vaccines Immunity Immunization 97

NY Times

DECEMBER 7, 2020

The British-Swedish drugmaker has joined with a huge Asian company to produce a Covid-19 vaccine in China, where shady reputations are common in the pharmaceutical industry.

Vaccines 112

Vaccines Immunity Immunization 112

NY Times

AUGUST 23, 2021

The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.

Vaccines 98

Vaccines Hospitals Immunity Immunization 98

NY Times

MAY 3, 2021

President Biden and drugmakers are facing demands from liberal activists and global leaders to suspend intellectual property rights on the vaccines as the pandemic surges.

Vaccines 98

Vaccines Immunity Immunization 98

NY Times

JULY 12, 2021

Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.

Vaccines 112

Vaccines Immunity Immunization 112

NY Times

NOVEMBER 28, 2021

A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.

Vaccines 108

Vaccines Immunization Immunity 108

NY Times

APRIL 28, 2021

billion doses of the Pfizer-BioNTech vaccine after a dispute with AstraZeneca derailed its vaccination campaign. The European Union is about to sign a deal for 1.8 Here’s how it came about.

Vaccines 104

Vaccines Immunity Immunization 104

NY Times

FEBRUARY 24, 2021

VaccineFinder.org is an ambitious but limited attempt to simplify Americans’ search for vaccines.

Vaccines 104

Vaccines Immunity Immunization 104

NY Times

APRIL 26, 2021

President Biden will send up to 60 million doses of AstraZeneca’s vaccine to countries pleading for help, but some see a medicine dropper for “a four-alarm fire.”.

Vaccines 98

Vaccines Immunity Immunization 98

NY Times

JANUARY 29, 2021

Infectious disease doctors say getting a shot of the J&J vaccine, which has a lower efficacy against the virus than other vaccines, would still be well worthwhile.

Vaccines 104

Vaccines Immunity Immunization 104

NY Times

DECEMBER 20, 2021

The vaccine will be the fifth to become available in the E.U., which already has ample supplies.

Vaccines 98

Vaccines Immunity Immunization 98

NY Times

MAY 4, 2021

The company said its vaccine generated $3.5 billion in revenue in the first three months of this year.

Vaccines 104

Vaccines Immunity Immunization 104

NY Times

FEBRUARY 10, 2021

After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.

Vaccines 98

Vaccines Immunity Immunization 98

NY Times

JULY 26, 2021

wants Pfizer and Moderna to increase the number of 5- to 11-year-olds who participate in trials of their coronavirus vaccines to ensure there is enough data about rare side effects.

Vaccines 104

Vaccines Immunization Immunity 104

NY Times

JULY 6, 2021

The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request. In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading.

Vaccines 101

Vaccines Immunity Immunization 101

NY Times

JUNE 13, 2022

Outside experts will make their recommendations this week on how the agency should rule on applications from Pfizer and Moderna to vaccinate the nation’s youngest children.

Vaccines 104

Vaccines Immunity Immunization 104

NY Times

DECEMBER 28, 2020

Global inequality is shaping which countries get vaccines first. In South Africa, people’s best chance for vaccines anytime soon is to join an experimental trial.

Vaccines 98

Vaccines Immunity Immunization 98

NY Times

OCTOBER 14, 2021

Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s s advisers on vaccines are voting on this week? This scorecard may help.

Vaccines 98

Vaccines Immunity Immunization 98